CFLT Stock Recent News

Confluent's financial results were much better than many had feared. The company's guidance for the coming year also came in above expectations, giving the stock a boost.

While the top- and bottom-line numbers for Confluent (CFLT) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Confluent, Inc. (CFLT) Q4 2023 Earnings Call Transcript

Shares of Confluent CFLT, +3.45% rose late Wednesday after the data-streaming company forecast more than 20% revenue growth in 2024 and its first breakeven year based on certain metrics.

Confluent's (CFLT) fourth-quarter 2023 earnings and revenues are likely to increase year over year.

Get a deeper insight into the potential performance of Confluent (CFLT) for the quarter ended December 2023 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Pfizer's post-COVID hangover has created a temporary soft spot in its longer-term stock trajectory. Confluent's growth remains solid, even as its stock price has suffered.

Confluent (CFLT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The U.S. market for initial public offerings is expected to stage a recovery in 2024 from the drought of the last two years, buoyed by expectations the Federal Reserve will switch to a rate-cutting cycle and boost market conditions.

Confluent is scratching the surface of a massive market opportunity, which should allow it to sustain healthy long-term growth. ASML Holding is playing a central role in the semiconductor industry's growth and is expected to deliver healthy earnings growth in the long run.